Business Description
Biocon Ltd
ISIN : INE376G01013
Share Class Description:
BOM:532523: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIOCON.India IPO Date
2004-04-07Description
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.96 | |||||
| Debt-to-EBITDA | 4.32 | |||||
| Interest Coverage | 2.26 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.15 | |||||
| Beneish M-Score | -0.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.9 | |||||
| 3-Year EBITDA Growth Rate | 9.6 | |||||
| 3-Year EPS without NRI Growth Rate | -9 | |||||
| 3-Year Book Growth Rate | 38.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 79.51 | |||||
| 9-Day RSI | 70.43 | |||||
| 14-Day RSI | 64.3 | |||||
| 6-1 Month Momentum % | 12.34 | |||||
| 12-1 Month Momentum % | 9.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.36 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.38 | |||||
| Days Inventory | 307.57 | |||||
| Days Sales Outstanding | 83.3 | |||||
| Days Payable | 255.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.51 | |||||
| Dividend Payout Ratio | 0.17 | |||||
| Forward Dividend Yield % | 0.51 | |||||
| 5-Year Yield-on-Cost % | 0.52 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | -38.38 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.06 | |||||
| Operating Margin % | 15.91 | |||||
| Net Margin % | 8.48 | |||||
| FCF Margin % | 0.89 | |||||
| ROE % | 7.75 | |||||
| ROA % | 2.79 | |||||
| ROIC % | 5.52 | |||||
| ROC (Joel Greenblatt) % | 20.92 | |||||
| ROCE % | 7.62 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.16 | |||||
| PE Ratio without NRI | 32.42 | |||||
| Shiller PE Ratio | 38.84 | |||||
| Price-to-Owner-Earnings | 66.8 | |||||
| PEG Ratio | 2.47 | |||||
| PS Ratio | 2.39 | |||||
| PB Ratio | 1.78 | |||||
| Price-to-Free-Cash-Flow | 267.7 | |||||
| Price-to-Operating-Cash-Flow | 18.23 | |||||
| EV-to-EBIT | 18.24 | |||||
| EV-to-EBITDA | 11.65 | |||||
| EV-to-Revenue | 3.49 | |||||
| EV-to-FCF | 370.49 | |||||
| Price-to-Projected-FCF | 3.86 | |||||
| Price-to-DCF (Earnings Based) | 3.27 | |||||
| Price-to-DCF (FCF Based) | 29.77 | |||||
| Price-to-Median-PS-Value | 0.47 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.91 | |||||
| Earnings Yield (Greenblatt) % | 5.48 | |||||
| FCF Yield % | 0.37 | |||||
| Forward Rate of Return (Yacktman) % | 11.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biocon Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 141,461 | ||
| EPS (TTM) (₹) | 10.03 | ||
| Beta | 0.6 | ||
| Volatility % | 29.04 | ||
| 14-Day RSI | 64.3 | ||
| 14-Day ATR (₹) | 9.398342 | ||
| 20-Day SMA (₹) | 271.005 | ||
| 12-1 Month Momentum % | 9.23 | ||
| 52-Week Range (₹) | 217.5 - 307 | ||
| Shares Outstanding (Mil) | 1,196.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biocon Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biocon Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biocon Ltd Frequently Asked Questions
What is Biocon Ltd(BOM:532523)'s stock price today?
The current price of BOM:532523 is ₹291.70. The 52 week high of BOM:532523 is ₹307.00 and 52 week low is ₹217.50.
When is next earnings date of Biocon Ltd(BOM:532523)?
The next earnings date of Biocon Ltd(BOM:532523) is 2024-05-31 Est..
Does Biocon Ltd(BOM:532523) pay dividends? If so, how much?
The Dividend Yield %  of Biocon Ltd(BOM:532523) is 0.51% (As of Today), Highest Dividend Payout Ratio of Biocon Ltd(BOM:532523) was 0.47. The lowest was 0.08. And the median was 0.18. The  Forward Dividend Yield % of Biocon Ltd(BOM:532523) is 0.51%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers